Aromatase Deficiency due to a Novel Mutation in CYP19A1 Gene

被引:14
|
作者
Unal, Edip [1 ]
Yildirim, Ruken [2 ]
Tas, Funda Feryal [1 ]
Demir, Vasfiye [3 ]
Onay, Huseyin [4 ]
Haspolat, Yusuf Kenan [1 ]
机构
[1] Dicle Univ, Fac Med, Dept Pediat Endocrinol, Diyarbakir, Turkey
[2] Diyarbakir Childrens Hosp, Clin Pediat Endocrinol, Diyarbakir, Turkey
[3] Kocakoy Family Hlth Ctr, Diyarbakir, Turkey
[4] Ege Univ, Fac Med, Dept Med Genet, Izmir, Turkey
关键词
Aromatase deficiency; CYP19A1; gene; maternal virilization; ambiguous genitalia; ESTROGEN REPLACEMENT; HYPERGONADOTROPIC HYPOGONADISM; MULTICYSTIC OVARIES; POINT MUTATIONS; ADULT MAN; FEMALE; BONE; CHILDHOOD; ESTRADIOL; INSIGHTS;
D O I
10.4274/jcrpe.0011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aromatase deficiency is a rare autosomal recessive genetic disorder with an unknown incidence. Aromatase converts androgens into estrogen in the gonadal and extra-gonadal tissues. Aromatase deficiency causes ambiguous genitalia in the Female fetus and maternal virilization (hirsutism, acne, cliteromegaly, deep voice) during pregnancy due to increased concentration of androgens. A 19 months old girl patient was assessed due to presence of ambiguous genitalia. There were findings of maternal virilization during pregnancy. The karyotype was 46,XX. Congenital adrenal hyperplasia was not considered since adrenocorticotropic hormone, cortisol, and 17-hydroxyprogesterone levels were within normal ranges. At age two months, follicle-stimulating hormone and total testosterone levels were elevated and estradiol level was low. Based on these findings, aromatase deficiency was suspected. A novel homozygous mutation IVS7-2A > G (c.744-2A >G) was identified in the CYP19A1 gene. Pelvic ultrasound showed hypoplasic ovaries rather than large and cystic ovaries. We identified a novel mutation in the CYP19A1 gene in a patient who presented with ambiguous genitalia and maternal virilization during pregnancy. Presence of large and cystic ovaries is not essential in aromatase deficiency.
引用
收藏
页码:377 / 381
页数:5
相关论文
共 50 条
  • [21] Mechanisms in the regulation of aromatase/CYP19A1 gene expression during human trophoblast differentiation
    Mendelson, Carole R.
    Kumar, Premlata
    [J]. ENDOCRINE JOURNAL, 2010, 57 : S257 - S257
  • [22] The Aromatase Gene (CYP19A1) Variants and Circulating Hepatocyte Growth Factor in Postmenopausal Women
    Lin, Jennifer H.
    Gunter, Marc J.
    Manson, Joann E.
    Rexrode, Kathryn M.
    Cook, Nancy R.
    Kraft, Peter
    Cochrane, Barbara B.
    Chlebowski, Rowan T.
    Ho, Gloria Y. F.
    Zhang, Shumin M.
    [J]. PLOS ONE, 2012, 7 (07):
  • [23] Single nucletotide polymorphisms of aromatase gene (CYP19A1) and toxicity of adjuvant aromatase inhibitors: A translational, prospective study
    Conte, Benedetta
    Molinelli, Chiara
    Bisagni, Giancarlo
    Durando, Antonio
    Sanna, Giovanni
    Gori, Stefania
    Garrone, Ornella
    Tamberi, Stefano
    De Placido, Sabino
    Schettini, Francesco
    Pazzola, Antonio
    Ponzone, Riccardo
    Montemurro, Filippo
    Lunardi, Gianluigi
    Notaro, Rosario
    Turletti, Anna
    Bighin, Claudia
    Poggio, Francesca
    Buzzatti, Giulia
    Lambertini, Matteo
    Boni, Luca
    Del Mastro, Lucia
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [24] Polymorphisms of the aromatase gene (CYP19A1) and benefit of aromatase inhibitors (AIs) in metastatic breast cancer (mBC) patients
    Arnedos, M.
    Ferraldeschi, R.
    A'Hern, R.
    Hadfield, K.
    Roberts, S.
    Drury, S.
    Howell, A.
    Evans, D. G.
    Wardley, A. M.
    Smith, I. E.
    Newman, W. G.
    Dowsett, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [25] CYP19A1 AMPLIFICATION PROMOTES ACQUIRED RESISTANCE TO AROMATASE INHIBITORS
    不详
    [J]. CANCER DISCOVERY, 2017, 7 (03) : 247 - 247
  • [26] Aromatase excess syndrome in a family with upstream deletion of CYP19A1
    Shihara, Daizou
    Miyado, Mami
    Nakabayashi, Kazuhiko
    Shozu, Makio
    Ogata, Tsutomu
    Nagasaki, Keisuke
    Fukami, Maki
    [J]. CLINICAL ENDOCRINOLOGY, 2014, 81 (02) : 314 - 316
  • [27] Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene
    Herrmann, BL
    Saller, B
    Janssen, OE
    Gocke, P
    Bockisch, A
    Sperling, H
    Mann, K
    Broecker, M
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (12): : 5476 - 5484
  • [28] A Fluorometric CYP19A1 (Aromatase) Activity Assay in Live Cells
    Heidary, David K.
    Kriger, Sarah M.
    Hachey, Austin C.
    Glazer, Edith C.
    [J]. CHEMMEDCHEM, 2021, 16 (18) : 2845 - 2850
  • [29] Aromatase (CYP19A1) gene variants, sex steroid levels, and late-life depression
    Ancelin, Marie-Laure
    Norton, Joanna
    Canonico, Marianne
    Scarabin, Pierre-Yves
    Ritchie, Karen
    Ryan, Joanne
    [J]. DEPRESSION AND ANXIETY, 2020, 37 (02) : 146 - 155
  • [30] In silico analysis of nsSNPs in CYP19A1 gene affecting breast cancer associated aromatase enzyme
    Pavithran, Honey
    Kumavath, Ranjith
    [J]. JOURNAL OF GENETICS, 2021, 100 (02)